CYAD

Celyad Oncology S.A. CYAD

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CYAD IMNN SQZB REUN AXLA KA TLPH ATON HURA GLS
6M -52.53 % -73.60 % -14.29 % 5.16 % 0.00 % 18.21 % 152.80 % -89.38 % -63.07 % -43.56 %
YTD -6.00 % -78.98 % -20.00 % 7.69 % 0.00 % -83.10 % 91.49 % -86.70 % -79.96 % -69.50 %
1Y -74.18 % -72.07 % -12.73 % -69.61 % 0.00 % -83.49 % 123.76 % -88.39 % -81.90 % -96.44 %
3Y -96.18 % -83.16 % -96.48 % -88.58 % -89.71 % -98.76 % -43.50 % -99.27 % -89.32 % -98.39 %
5Y -98.23 % -98.04 % -99.93 % -88.58 % -96.03 % -99.28 % -95.33 % -99.79 % -98.81 % -98.39 %
10Y -99.14 % -99.95 % -99.82 % -88.58 % -98.67 % -99.92 % -98.52 % -99.75 % -99.96 % -98.39 %
From the beginning -99.14 % -100.00 % -99.82 % -88.58 % -98.67 % -99.92 % -98.76 % -99.70 % -99.98 % -98.39 %

Dividend

Kineta, Inc.